Michael Gold

10.3k total citations
187 papers, 6.1k citations indexed

About

Michael Gold is a scholar working on Epidemiology, Immunology and Allergy and Psychiatry and Mental health. According to data from OpenAlex, Michael Gold has authored 187 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 37 papers in Immunology and Allergy and 37 papers in Psychiatry and Mental health. Recurrent topics in Michael Gold's work include Food Allergy and Anaphylaxis Research (37 papers), Vaccine Coverage and Hesitancy (35 papers) and Dementia and Cognitive Impairment Research (23 papers). Michael Gold is often cited by papers focused on Food Allergy and Anaphylaxis Research (37 papers), Vaccine Coverage and Hesitancy (35 papers) and Dementia and Cognitive Impairment Research (23 papers). Michael Gold collaborates with scholars based in Australia, United States and United Kingdom. Michael Gold's co-authors include Maria Makrides, Debra J. Palmer, Peter M. Bentler, Susan L. Prescott, Thomas Sullivan, Kenneth M. Heilman, Kurt Lushington, Danny Camfferman, John F. Kennedy and Marina Zvartau‐Hind and has published in prestigious journals such as NeuroImage, Brain and American Journal of Clinical Nutrition.

In The Last Decade

Michael Gold

184 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Gold Australia	44	1.7k	1.5k	947	884	764	187	6.1k
Susanne S. Pedersen Denmark	64	3.1k 1.9×	392 0.3×	818 0.9×	378 0.4×	883 1.2×	456	14.6k
Sydne J Newberry United States	33	607 0.4×	331 0.2×	582 0.6×	454 0.5×	281 0.4×	103	5.5k
Marika J Suttorp United States	37	1.6k 1.0×	327 0.2×	1.2k 1.3×	1.4k 1.6×	1.2k 1.6×	85	9.2k
Tamàs Fülöp Canada	67	4.3k 2.6×	247 0.2×	1.8k 1.9×	390 0.4×	484 0.6×	300	14.5k
Jacqueline W Lucas United States	16	1.1k 0.7×	198 0.1×	510 0.5×	1.2k 1.3×	410 0.5×	23	5.1k
Elizabeth C. Wright United States	62	1.8k 1.1×	340 0.2×	5.1k 5.4×	175 0.2×	822 1.1×	185	13.8k
Calogero Caruso Italy	59	3.2k 1.9×	439 0.3×	2.3k 2.4×	344 0.4×	244 0.3×	346	12.6k
Myeong Soo Lee South Korea	62	2.0k 1.2×	173 0.1×	548 0.6×	2.5k 2.9×	1.6k 2.2×	672	15.5k
Tsai‐Chung Li Taiwan	45	1.3k 0.8×	136 0.1×	1.2k 1.2×	530 0.6×	405 0.5×	325	7.2k
Curtis L. Meinert United States	40	1.3k 0.8×	181 0.1×	842 0.9×	763 0.9×	1.5k 2.0×	127	7.6k

Countries citing papers authored by Michael Gold

Since Specialization

Citations

This map shows the geographic impact of Michael Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gold more than expected).

Fields of papers citing papers by Michael Gold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gold. The network helps show where Michael Gold may publish in the future.

Co-authorship network of co-authors of Michael Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gold. A scholar is included among the top collaborators of Michael Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gold. Michael Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathew, Sanjay J., et al.. (2025). Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 45(3). 267–276. 1 indexed citations

Wang, Xiaofang, Melanie Lloyd, Sarah Ashley, et al.. (2024). Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (PPOIT‐003LT) study. Allergy. 79(10). 2759–2774. 2 indexed citations

Ashley, Sarah, Melanie Lloyd, Francesca Orsini, et al.. (2024). Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years. Allergy. 80(3). 843–848. 2 indexed citations

Mathew, Sanjay J., et al.. (2024). Navacaprant, a Novel Kappa Opioid Receptor Antagonist for Major Depressive Disorder: A Randomized Placebo-Controlled Phase 2 Trial. Biological Psychiatry. 95(10). S10–S10. 1 indexed citations

Florian, Hana, Deli Wang, Steven E. Arnold, et al.. (2023). Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study. Brain. 146(6). 2275–2284. 74 indexed citations

Lloyd, Melanie, Sarah Ashley, Adriana Chebar Lozinsky, et al.. (2023). Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 1019–1028.e2. 4 indexed citations

Lloyd, Melanie, Adriana Chebar Lozinsky, Michael O’Sullivan, et al.. (2023). Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy. The Journal of Allergy and Clinical Immunology In Practice. 11(10). 3195–3202.e4.

Biggs, Sarah N., Jillian Dorrian, James Martin, et al.. (2022). Allergic disease, sleep problems, and psychological distress in children recruited from the general community. Annals of Allergy Asthma & Immunology. 129(3). 366–372. 8 indexed citations

Perkins, Griffith B., Tania Salehi, Frank Kette, et al.. (2022). COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Internal Medicine Journal. 52(11). 1884–1890. 1 indexed citations

10.

Palmer, Debra J., Thomas Sullivan, Dianne E. Campbell, et al.. (2022). PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks’ gestation during pregnancy to 4 months’ lactation on infant IgE-mediated egg and peanut allergy outcomes. BMJ Open. 12(6). e056925–e056925. 15 indexed citations

11.

Campbell, Dianne E., Debra J. Palmer, Maria Makrides, et al.. (2020). Longitudinal egg‐specific regulatory T‐ and B‐cell development: Insights from primary prevention clinical trials examining the timing of egg introduction. Allergy. 76(5). 1385–1397. 10 indexed citations

12.

Lozinsky, Adriana Chebar, Francesca Orsini, Michael O’Sullivan, et al.. (2020). Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study). BMJ Open. 10(9). e035871–e035871. 9 indexed citations

13.

Estcourt, Marie J., Dianne E. Campbell, Kirsten P. Perrett, et al.. (2020). OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. BMJ Open. 10(12). e042838–e042838. 7 indexed citations

14.

Damiano, John A., Lucy Deng, Wenhui Li, et al.. (2019). SCN1A Variants in vaccine‐related febrile seizures: A prospective study. Annals of Neurology. 87(2). 281–288. 18 indexed citations

15.

Pillsbury, Alexis, Catherine Glover, Peter Jacoby, et al.. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open. 8(10). e023263–e023263. 37 indexed citations

16.

Cashman, Patrick, Kristine Macartney, Gulam Khandaker, et al.. (2017). Participant-centred active surveillance of adverse events following immunisation: a narrative review. International Health. 9(3). 164–176. 30 indexed citations

17.

Palmer, Debra J., Thomas Sullivan, Michael Gold, Susan L. Prescott, & Maria Makrides. (2016). Randomized controlled trial of early regular egg intake to prevent egg allergy. Journal of Allergy and Clinical Immunology. 139(5). 1600–1607.e2. 142 indexed citations

18.

Palmer, Debra J., Thomas Sullivan, Michael Gold, et al.. (2013). Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy. 68(11). 1370–1376. 60 indexed citations

19.

Gold, Michael. (2012). A clinical approach to the investigation of suspected vaccine anaphylaxis : review article. 25(2). 68–70. 2 indexed citations

20.

Harrington, Conn, Sharon Sawchak, Carl Chiang, et al.. (2009). P4‐299: Effects Of Rosiglitazone‐extended Release As Adjunctive Therapy To Acetylcholinesterase Inhibitors Over 48 Weeks On Cognition In Apoe4‐stratified Subjects With Mild‐to‐moderate Alzheimer's Disease. Alzheimer s & Dementia. 5(4S_Part_17). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact